What is a peptide stack?
"Stacking" is a term borrowed from bodybuilding: using several compounds at once in the hope their effects combine. A peptide stack applies the idea to peptides — for example pairing a "healing" peptide with a "recovery" peptide, or a growth-hormone-releasing peptide with a growth-hormone-releasing hormone analog.
Two things are worth understanding up front. First, the popular named stacks are marketing shorthand, not tested formulations — the acronyms come from vendors and forums, not clinical trials. Second, and more important: nearly all of these combine peptides that are unapproved "research chemicals" in the first place. Combining two unproven compounds does not create a proven one — it stacks their uncertainties. See how peptide research is graded.
The healing & recovery stacks (Wolverine, GLOW, KLOW)
The best-known named stacks center on tissue repair and combine the same handful of peptides. Each links to its full guide:
| Stack | What's in it | Marketed for |
|---|---|---|
| Wolverine | BPC-157 + TB-500 | Injury recovery, tendon & soft-tissue healing |
| GLOW | BPC-157 + TB-500 + GHK-Cu | The above plus skin, hair & "glow" (copper peptide) |
| KLOW | BPC-157 + TB-500 + GHK-Cu + KPV | The above plus an anti-inflammatory peptide (KPV) |
The logic marketers give is that BPC-157 and TB-500 target tissue repair through different mechanisms, GHK-Cu adds a skin/collagen angle, and KPV adds anti-inflammatory action. The critical caveat: the evidence for the individual peptides here is largely animal-based, and there are no human trials of these combinations at all. The "Wolverine" name promises comic-book healing the data does not support.
Growth-hormone stacks
The other classic category pairs two growth-hormone peptides that act on complementary receptors. The most common is CJC-1295 + ipamorelin — a GHRH analog plus a growth-hormone-releasing peptide — on the theory that hitting both pathways produces a larger pulse of the body's own growth hormone than either alone. Related combinations swap in sermorelin, tesamorelin, or GHRP-2/GHRP-6.
Here too, the mechanism is real but the human outcome evidence for muscle, fat loss, or anti-aging is thin to absent, and all growth-hormone secretagogues are banned in sport by WADA. See the muscle-growth category and our ipamorelin vs CJC-1295 comparison.
The approved "stacks": combination drugs
There is one place the stacking idea has been done properly — as formulated combination drugs tested in trials. The clearest example is CagriSema, which combines the amylin analog cagrilintide with the GLP-1 drug semaglutide in a single, dose-controlled product studied in large Phase 3 trials. That is a world apart from a DIY stack of research chemicals: the dose is fixed, the quality is controlled, and the combination itself was tested. It's a useful contrast — a "stack" can be legitimate when it's an actual regulated product with combination data behind it.
The honest reality check
Before treating any stack as a shortcut, weigh the following:
- Unproven times two. Combining unapproved peptides doesn't add evidence; it multiplies unknowns. There are essentially no human trials of the popular DIY stacks.
- Multiplied risk. Each unregulated peptide carries its own purity, sterility, and dosing risks; stacking several compounds and injection sites compounds them. See are peptides safe? and peptide side effects.
- Legal grey zone. Most stacked peptides are unapproved research chemicals — see are peptides legal?
- No dosing here. We don't publish stack recipes or dosing protocols for unapproved compounds. This page explains what the terms mean, not how to use them.
Frequently asked questions
What is the Wolverine stack?
The 'Wolverine stack' is an informal combination of two research peptides, BPC-157 and TB-500, marketed for injury recovery and soft-tissue healing. The name is fitness-community marketing, not an official product — and there are no human trials of the combination; the evidence for each peptide individually is mostly from animal studies.
What is in the GLOW and KLOW peptide stacks?
GLOW is BPC-157 + TB-500 + GHK-Cu (the copper peptide), adding a skin and hair angle to the healing stack. KLOW adds a fourth peptide, KPV, for its anti-inflammatory action. Both are informal marketing bundles of unapproved peptides with no human trials of the combinations.
What is the CJC-1295 and ipamorelin stack?
It combines a GHRH analog (CJC-1295) with a growth-hormone-releasing peptide (ipamorelin), on the theory that acting on two complementary pathways produces a larger release of the body's own growth hormone. The mechanism is real, but human outcome evidence is thin and both are banned in sport.
Are peptide stacks safe?
Their safety is unproven. Combining peptides that are themselves unapproved research chemicals multiplies the unknowns, and each unregulated product adds purity, sterility, and dosing risks. There are essentially no human trials of the popular DIY stacks.
Are peptide stacks legal?
Most stacked peptides are unapproved 'research chemicals' sold for laboratory use, which puts them in a legal grey area for human use, and growth-hormone stacks are banned in sport. Legality depends on the specific peptides and your country — see our guide on whether peptides are legal.
Do peptide stacks work better than single peptides?
There's no good evidence they do. The idea that combining peptides multiplies benefits is a marketing premise, not a tested finding — the popular stacks have no human trials. A properly tested combination, like the approved-pathway drug CagriSema, is a very different thing from a DIY stack of research chemicals.
Further reading
Selected peer-reviewed sources on this topic, labelled by type. A citation is a reference, not an endorsement.
- Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022. Peer-reviewed study
- Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021. Peer-reviewed study
- Lau JL, Dunn MK. Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorg Med Chem. 2018. Peer-reviewed study